In 2010, Cannabinoids as novel anti-inflammatory drugs

BACKGROUND: This review will focus on the potential use of cannabinoids as a new class of anti-inflammatory agents against a number of inflammatory and autoimmune diseases that are primarily triggered by activated T cells or other cellular immune components.

You can read the full article here => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/